Phibro Animal Health (PAHC)
(Delayed Data from NSDQ)
$17.74 USD
-0.77 (-4.16%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $17.70 -0.04 (-0.23%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
PAHC 17.74 -0.77(-4.16%)
Will PAHC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PAHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PAHC
Baxter (BAX) to Report Q2 Earnings: What's in the Cards?
Cencora (COR) to Report Q3 Earnings: Is a Beat in Store?
PAHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stryker (SYK) to Report Q2 Earnings: What's in the Cards?
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Zacks Value Trader Highlights: Great Lakes Dredge & Dock, HanesBrands, Lands' End, Phibro Animal Health and Wolverine World Wide
Other News for PAHC
Phibro Animal Health Corporation Declares Quarterly Dividend
Phibro Animal declares $0.12 dividend
How To Invest In Small Cap Value Stocks In 2024
Phibro Animal Health Corporation Releases Third Annual ESG Report: Connections that Advance Animal Health, Nutrition and Sustainability
Phibro Animal goes ex dividend tomorrow